Showing results (1-10 of 40) with videos related to
Sort By:
Pageof 4
Advances in Experimental Medicine and Biology|November 5, 2015
The Role of CA 125 as Tumor Marker: Biochemical and Clinical AspectsPatrizia Bottoni, Roberto ScatenaCurrent Medicinal Chemistry|August 24, 2019
The Tangled Mitochondrial Metabolism in Cancer: An Innovative Pharmacological ApproachPatrizia Bottoni, Roberto ScatenaAdvances in Experimental Medicine and Biology|August 28, 2019
Mitochondrial Metabolism in Cancer. A Tangled Topic. Which Role for Proteomics?Patrizia Bottoni, Roberto ScatenaAdvances in Experimental Medicine and Biology|November 5, 2015
CA 19-9: Biochemical and Clinical AspectsSalvatore Scarà, Patrizia Bottoni, Roberto ScatenaProteomics. Clinical Applications|December 8, 2010
Modulation of cancer cell line differentiation: A neglected proteomic analysis with potential implications in pathophysiology, diagnosis, prognosis, and therapy of cancerRoberto Scatena, Patrizia Bottoni, Bruno GiardinaInternational Journal of Molecular Sciences|January 8, 2023
Remarks on Mitochondrial MyopathiesPatrizia Bottoni, Giulia Gionta, Roberto ScatenaPPAR Research|July 23, 2008
Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key?Roberto Scatena, Patrizia Bottoni, Bruno GiardinaBiochimica Et Biophysica Acta|December 12, 2012
Circulating tumour cells and cancer stem cells: a role for proteomics in defining the interrelationships between function, phenotype and differentiation with potential clinical applicationsRoberto Scatena, Patrizia Bottoni, Bruno GiardinaProteomics. Clinical Applications|December 8, 2010
Proteomic profiling of heat shock proteins: An emerging molecular approach with direct pathophysiological and clinical implicationsPatrizia Bottoni, Bruno Giardina, Roberto ScatenaAdvances in Experimental Medicine and Biology|November 5, 2015
Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical AspectsMaria Antonietta Isgrò, Patrizia Bottoni, Roberto ScatenaPageof 4